MBOT

Microbot Medical Inc.
CAPPED RATING

Microbot Medical Inc is a pre-clinical medical device company. It specializes in research, design and development of next generation micro-robotics assisted medical technologies.

Microbot Medical Inc. (MBOT) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D). The rating has held at C for 13 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
D+
Factor Score 1.7 / 5.0
Growth
B
Factor Score 3.3 / 5.0
Profitability
C
Factor Score 2.4 / 5.0
Momentum
D
Factor Score 1.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -3.2
EV / EBITDA -0.1
Rev Growth YoY N/A
Gross Margin N/M
Price Return 3M -33.5%
Price Return 12M -50.7%
Catalyst Signal 0.00
Market Cap $69.2M
TTM Revenue $346.0K
Price / Sales 199.9
ROE -32.9%

Historical Factor Score Progression

Held C for 13 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 D+ (1.7) B (3.3) C (2.4) D (1.5) C+ (2.6) C (2.3)
2026-11-06 D+ (1.7) B (3.3) C (2.4) D (1.2) C+ (2.7) C (2.3)
2026-10-30 D+ (1.7) B (3.2) C (2.2) D (1.4) C+ (2.7) C (2.2)
2026-10-23 C+ (2.8) B (3.3) C (2.2) D (1.2) C+ (2.6) C (2.4)
2026-10-16 C+ (2.8) B (3.3) C (2.2) D (1.2) C+ (2.6) C (2.4)
Page 1 of 6